(Q39279759)
Statements
Molecular mechanisms and modulation of key pathways underlying the synergistic interaction of sorafenib with erlotinib in non-small-cell-lung cancer (NSCLC) cells (English)
M Labots
E Galvani
J S W Lind
R Honeywell
E F Smit